ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,846Medicare Part D Prescriptions Filled, Including Refills

Rank: 375 out of 2588

$554K Total Retail Price of All Prescriptions

Rank: 386 out of 2588

307 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 307 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

23% of this provider’s 307 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 8,006 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
WARFARIN SODIUM 433 371 1 10
LEVOTHYROXINE SODIUM 354 332 2 2
SIMVASTATIN 328 274 3 1
LISINOPRIL 307 286 4 3
OMEPRAZOLE 300 256 5 6
FUROSEMIDE 288 247 6 5
HYDROCODONE-ACETAMINOPHEN 238 148 S3 7 7
METOPROLOL TARTRATE 200 180 8 9
AMLODIPINE BESYLATE 169 155 9 4
NAMENDA 150 148 10 32
CARVEDILOL 143 108 11 20
CITALOPRAM HBR 137 132 12 27
PANTOPRAZOLE SODIUM 133 100 13 28
LANTUS 126 102 14 47
CLOPIDOGREL 121 97 15 30
RISPERIDONE 110 109 16 57
ATORVASTATIN CALCIUM 110 103 16 11
ESCITALOPRAM OXALATE 109 83 18 68
DONEPEZIL HCL 109 109 18 22
TAMSULOSIN HCL 105 101 20 23
TRAMADOL HCL 100 77 21 19
FAMOTIDINE 99 75 22 36
ZOLPIDEM TARTRATE 98 81 23 24
HYDRALAZINE HCL 95 84 24 53
POLYETHYLENE GLYCOL 3350 92 88 25 55
METFORMIN HCL 91 91 26 8
METOPROLOL SUCCINATE 88 76 27 12
POTASSIUM CHLORIDE 87 58 28 15
GABAPENTIN 83 50 29 18
SPIRONOLACTONE 83 80 29 58
AMIODARONE HCL 83 76 29 156
TRAZODONE HCL 79 69 32 61
PLAVIX 77 65 33 43
CARBIDOPA-LEVODOPA 77 70 33 83
BUMETANIDE 76 68 35 117
DIVALPROEX SODIUM 75 62 36 89
MIRTAZAPINE 74 71 37 63
ENALAPRIL MALEATE 72 64 38 31
HYDROCHLOROTHIAZIDE 71 57 39 13
KLOR-CON M20 69 69 40 52
FENTANYL 68 53 S2 41 78
GLIMEPIRIDE 67 55 42 39
LIDODERM 65 62 43 86
PAROXETINE HCL 62 48 44 71
LOSARTAN POTASSIUM 60 28 45 17
PRAVASTATIN SODIUM 60 47 45 16
LEVETIRACETAM 57 34 47 90
AZITHROMYCIN 56 38 48 45
ISOSORBIDE MONONITRATE ER 55 51 49 49
CEPHALEXIN 55 49 49 138
KLOR-CON M10 54 42 51 139
DIGOXIN 54 42 51 38
CYCLOBENZAPRINE HCL 54 43 R 51 87
FLUOXETINE HCL 54 43 51 92
VESICARE 52 42 55 172
ADVAIR DISKUS 51 32 56 48
DIOVAN 50 46 57 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.